270 articles
Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing power of semaglutide — the active ingredient in Ozempic — without the...
New Study Shows Experimental Drug Targets Gut-Liver Connection to Treat MASH An experimental drug developed at Michigan Medicine has shown remarkable results in reversing severe...
For millions of people worldwide, a trip to the dentist triggers anxiety, fear, and dread. But what if that visit could one day involve regrowing...
Breakthrough Study Confirms Focal Therapy Offers Safer, Effective Treatment for Prostate Cancer A landmark 10-year NHS study led by Imperial College London has delivered compelling...
Millions of Seniors Gain Access to Affordable Weight-Loss Medications In a historic shift in public health policy, Medicare has officially begun covering GLP-1 weight-loss drugs...
Breaking: Nationwide Recall of Chlorthalidone Tablets Raises Concerns for Hypertension Patients The U.S. Food and Drug Administration (FDA) has announced a voluntary nationwide recall of...
A major new study involving more than 110,000 women has found that popular GLP-1 weight-loss and diabetes drugs — including Ozempic, Wegovy, Mounjaro, and Zepbound...
A major study of 600,000 veterans finds GLP-1 weight loss drugs like Ozempic may reduce addiction risk and opioid overdose by up to 40%. New hope for addiction treatment.
Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other...
Jaff, Vice President and Chief Medical Officer, Peripheral Interventions at Boston Scientific and Dr. Learn more on Health Professional Radio.